GSK Investigational Site

St-Charles-Borromée, Ontario J6E 2B4

0 studies enrolling now · 3 studies all time

What they study most

Asthma

Studies at this site

• A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects — Completed
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control — Completed
• Cross-sectional Study for Identification and Description of Severe Asthma Patients — Completed